IVF - INVO Fertility Total Debt to Capital

This daily price chart for INVO Fertility Inc (IVF) reflects a total debt-to-equity ratio of 0.23. The company's financial position is complicated by significant loans and asset consolidation challenges, which are slowing revenue growth. Business success depends on the implementation of the INVOcell system and the cost of such procedures relative to conventional IVF. Meanwhile, the market values INVO Fertility Inc (IVF) for its accessibility of reproductive care.

IVF: invobioscience.com Total Debt to Equity Ratio 04/29/2025 - 10/30/2026

Analytical breakdowns and data insights for company INVO Fertility Corp (IVF)

- price and consensus price forecast:
Price Chart INVO Fertility|IVF - Forecast Levels Chart
- market capitalization statistics:
Market Capitalization INVO Fertility|IVF - Total Enterprise Value
- book capitalization indicators:
Book Value per Share INVO Fertility|IVF - Company Net Assets|Market Capitalization to Book Value Ratio invobioscience.com|IVF - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Total Debt to Capital INVO Fertility Inc|IVF - Long-Term Debt to Capital|Short-Term Debt to Equity INVO Fertility Inc|IVF - Company Debts|Debts to Book Capitalization INVO Fertility|IVF - Long-Term Debt Volume|Company Current Liabilities INVO Fertility|Quick Ratio invobioscience.com
- earnings and valuation multiples information:
IVF - Company Net Income
Summary company analysis:INVO Fertility, IVF

This indicator measures the proportion of borrowed funds within the financing structure, determining the degree of business dependence on creditors relative to equity. Analyzing the debt-to-equity ratio of INVO Fertility Inc (IVF) allows for an assessment of the extent to which the large-scale robotization of INVOcell production and the implementation of AI control are funded through external liabilities, which is critical for understanding the financial stability of INVO Fertility Inc (IVF).

Competitor analysis

Debt to Equity Boston Scientific Corporation|Edwards - Aggregate Debt to Equity|Total Debt to Capital RMD|PODD - Debt to Capital|Total Debt to Capital ZBH (Zimmer Biomet Corp)|COO - Total Debt to Equity Ratio|Align Technology - Total Debt to Capital|Total Debt to Capital Coefficient Globus Medical Inc GMED|TMDX: Total Debt to Capital|Alphatec Corp (ATEC) - Total Debt to Capital|Debt to Equity Artivion, Inc.|Debt to Equity ENOV|Total Debt to Capital IART|Total Debt to Capital Coefficient Establishment Labs Corp|Beta Bionics Corp - Total Debt to Equity Ratio|IRMD (IRADIMED Inc.) - Aggregate Debt to Equity|Embecta Corp. - Total Debt to Capital|Debt to Capital tandemdiabetes.com|AXGN: Total Debt to Capital|Debt to Equity Ratio SIBN|Total Debt to Equity Ratio OFIX|BVS: All Debt to Shareholders' Equity Ratio|Debt to Equity OrthoPediatrics Corp. (KIDS)|Total Debt to Equity Ratio treace.com TMCI|Total Debt to Capital SRTA (Strata Critical Medical)|Carlsmed, Inc. (CARL) - Debt to Capital|RxSight Corp - Total Debt to Capital|CLPT (ClearPoint Neuro, Inc.) - Debt to Equity Ratio|STXS: Total Debt to Capital|STIM - Total Debt to Capital Coefficient|SGHT (Sight Sciences) - Total Debt to Capital|Total Debt to Equity Ratio Orchestra BioMed Inc. (OBIO)|Total Debt to Capital ANIK|Total Debt to Capital InspireMD Inc. (NSPR)|Debt to Equity Jin Medical ZJYL|Vivani Medical Inc - Debt to Equity|XTNT: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio NMTC (NeuroOne)|MODD: Total Debt to Capital|Debt to Capital Myomo Inc (MYO)|Debt to Equity Envoy Medical, Inc.|VVOS - Debt to Capital Ratio|Total Debt to Equity Ratio NVNO (enVVeno Medical Corp.)|Total Debt to Capital sintx.com (SINT)|Total Debt to Capital TNON (Tenon Medical, Inc)|Total Debt to Capital Coefficient Lifeward Ltd. (LFWD)|AMIX - Debt to Equity|Aggregate Debt to Equity BBLG|Axonics (AXNX) - Debt to Equity|Total Debt to Equity Ratio BIOLASE Inc.|DYNT (Dynatronics Corp) - Total Debt to Capital|Debt to Capital Paragon 28 Corp FNA|Debt to Equity INVO Bioscience, Inc. (INVO)